News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Anup Trikannad shares findings on IVIG prophylaxis benefits in BCMA-directed bispecific therapy for MM
Anup Trikannad/union.health
Apr 26, 2025, 16:07

Anup Trikannad shares findings on IVIG prophylaxis benefits in BCMA-directed bispecific therapy for MM

Anup Trikannad, Internist in Little Rock, AR, shared a post on X about a paper he co-authored with colleagues published in Blood Cancer Journal:

“New multi-center study alert!

In patients receiving BCMA-directed bispecific antibodies, primary IVIG prophylaxis was linked to:

  • Better infection-free survival
  • Improved progression-free and overall survival
  • Independent predictor of favorable outcomes.”

“Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma”

Authors: Meera Mohan, Aniko Szabo, Heloise Cheruvalath, Anna Clennon, Vineel Bhatlapenumarthi, Binod Dhakal, Anup Trikannad, Samer Al-Hadidi, Anita D’Souza, Nishi Shah, Rajshekhar Chakraborty, Mansi Shah, Carolina Schinke et al.

Anup Trikannad shares findings on IVIG prophylaxis benefits in BCMA-directed bispecific therapy for MM

More posts featuring Anup Trikannad.

Aniko Szabo Anita D'Souza Anna Clennon Anup Trikannad Binod Dhakal cancer Carolina Schinke Heloise Cheruvalath Intravenous Immunoglobulin IVIG Mansi Shah Meera Mohan multiple myeloma Nishi Shah OncoDaily Oncology Rajshekhar Chakraborty Samer Al Hadidi Vineel Bhatlapenumarthi
Special Coverage
Blog
Apr 26, 2025, 16:17
Margaret Foti: We are making final preparations for the AACR 25 Opening Ceremony and Opening Plenary
Science
Apr 26, 2025, 16:07
Anup Trikannad shares findings on IVIG prophylaxis benefits in BCMA-directed bispecific therapy for MM
Blog
Apr 26, 2025, 15:56
Allison Rosen joins AACR Scientists–Survivor program as mentor
Career
Apr 26, 2025, 15:39
Fadlo Khuri: Greatly honored to have been elected to the American Academy of Arts and Sciences
Blog
Apr 26, 2025, 15:35
Elizabeth McKenna highlights Eli Van Allen's review on artificial intelligence in oncology
Insight
Apr 26, 2025, 15:08
Patrick Hwu: Can low-dose gut irradiation enhance the effectiveness of PD-L1 blockade in metastatic cancer?
Blog
Apr 26, 2025, 15:06
Touching on 2nd opinions, scanxiety, communication styles and cultural sensitivity - Lung Cancer Europe
Blog
Apr 26, 2025, 14:51
Yüksel Ürün: Expanding horizons in MIBC treatment
Science
Apr 26, 2025, 14:34
Talha Badar: Venetoclax plus 3+7 for newly diagnosed acute myeloid leukemia
Blog
Apr 26, 2025, 14:16
POEM 2025 Scientific Meeting: Key Sessions, Workshops, and Why You Should Attend
Blog
Apr 26, 2025, 13:55
Akshaya Keerti: I've always been a strong advocate of ADC shaping up the new treatment regimen and improving patient outcome
Blog
Apr 26, 2025, 13:26
Paolo Tarantino: Proud to be awarded a Conquer Cancer ASCO25 Merit Award